 the two treatments. The rate of death
or ipsilateral stroke at 30 days was 6.84% for CAS and 6.34%
for CEA in 1183 randomized patients. However, the study
was not powered appropriately and failed to show noninferiority of CAS compared with CEA (P â«½ .09).
Subsequently the International Carotid Stenting Study
Trial (ICST),10 which enrolled 1